Statins and the risk of new-onset diabetes: a review of recent evidence
Current Opinion in Lipidology,  Clinical Article

Preiss D et al. – The cardiovascular benefits of statin therapy clearly outweigh the risk of developing diabetes. However, the data suggest the need to make patients aware of this possible risk and to monitor patients for development of diabetes, especially on intensive–dose therapy.

  • Statins are the most prescribed medications worldwide with a proven ability to reduce major cardiovascular events.
  • Recent data have revealed that statin therapy is associated with an increased risk for developing diabetes.
  • Authors discuss the relevant data including newly published results, which demonstrate a dose–dependent association, authors place these findings in clinical context and authros consider clinical implications.
  • A recent meta–analysis of most major placebo and standard care–controlled statin trials with more than 90000 participants confirmed that statin therapy was associated with a 9% increased risk of developing diabetes.
  • Newly published data have confirmed a dose–dependent effect, with 12% higher risk of developing diabetes on intensive–dose statin therapy compared with moderate–dose therapy.
  • In this meta–analysis, one additional patient developed diabetes for every three patients protected from a major cardiovascular event.
  • The observation of higher diabetes risk remains unexplained at present, although studies in animal models suggest the possibility of impaired peripheral insulin signalling induced by statin therapy.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Pharmacy

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharmacy Articles

Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacistmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More